Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manisha Pandey

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
NPJ Vaccines|August 18, 2020
M-protein based vaccine induces immunogenicity and protection from <i>Streptococcus pyogenes</i> when delivered on a high-density microarray patch (HD-MAP)Jamie-Lee S Mills, Cesar M Jayashi Flores, Simone Reynolds, et al.
Current Drug Targets|May 25, 2018
Recent Updates on Novel Approaches in Insulin Drug Delivery: A Review of Challenges and Pharmaceutical ImplicationsManisha Pandey, Hira Choudhury, Cheah Xiao Yi, et al.
Pharmaceutics|April 23, 2022
Mucoadhesive Nanocarriers as a Promising Strategy to Enhance Intracellular Delivery against Oral Cavity CarcinomaManisha Pandey, Hira Choudhury, Jenifer Ngu Shao Ying, et al.
Materials Science & Engineering. C, Materials for Biological Applications|April 29, 2019
Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnologyHira Choudhury, Manisha Pandey, Tan Hui Yin, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 4, 2020
Molecular and Immunological Mechanisms Underlying the Various Pharmacological Properties of the Potent Bioflavonoid, RutinDavid O C Yong, Sanggetha R Saker, Dinesh K Chellappan, et al.
Mbio|June 16, 2016
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease ModelsTania Rivera-Hernandez, Manisha Pandey, Anna Henningham, et al.
Nature Communications|December 3, 2024
Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infectionsJoshua Osowicki, Hannah R Frost, Kristy I Azzopardi, et al.
Pharmaceutical Research|April 7, 2022
Recent Update on Bacteria as a Delivery Carrier in Cancer Therapy: From Evil to AlliesManisha Pandey, Hira Choudhury, Prathiba A/P Vijayagomaran, et al.
Science Advances|February 18, 2020
Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccinesMariusz Skwarczynski, Guangzu Zhao, Jennifer C Boer, et al.
Vaccine|May 19, 2019
Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection studyJoshua Osowicki, Kristy I Azzopardi, Ciara Baker, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
NPJ Vaccines|August 18, 2020
M-protein based vaccine induces immunogenicity and protection from <i>Streptococcus pyogenes</i> when delivered on a high-density microarray patch (HD-MAP)Jamie-Lee S Mills, Cesar M Jayashi Flores, Simone Reynolds, et al.
Current Drug Targets|May 25, 2018
Recent Updates on Novel Approaches in Insulin Drug Delivery: A Review of Challenges and Pharmaceutical ImplicationsManisha Pandey, Hira Choudhury, Cheah Xiao Yi, et al.
Pharmaceutics|April 23, 2022
Mucoadhesive Nanocarriers as a Promising Strategy to Enhance Intracellular Delivery against Oral Cavity CarcinomaManisha Pandey, Hira Choudhury, Jenifer Ngu Shao Ying, et al.
Materials Science & Engineering. C, Materials for Biological Applications|April 29, 2019
Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnologyHira Choudhury, Manisha Pandey, Tan Hui Yin, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 4, 2020
Molecular and Immunological Mechanisms Underlying the Various Pharmacological Properties of the Potent Bioflavonoid, RutinDavid O C Yong, Sanggetha R Saker, Dinesh K Chellappan, et al.
Mbio|June 16, 2016
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease ModelsTania Rivera-Hernandez, Manisha Pandey, Anna Henningham, et al.
Nature Communications|December 3, 2024
Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infectionsJoshua Osowicki, Hannah R Frost, Kristy I Azzopardi, et al.
Pharmaceutical Research|April 7, 2022
Recent Update on Bacteria as a Delivery Carrier in Cancer Therapy: From Evil to AlliesManisha Pandey, Hira Choudhury, Prathiba A/P Vijayagomaran, et al.
Science Advances|February 18, 2020
Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccinesMariusz Skwarczynski, Guangzu Zhao, Jennifer C Boer, et al.
Vaccine|May 19, 2019
Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection studyJoshua Osowicki, Kristy I Azzopardi, Ciara Baker, et al.
Pageof 15